AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2017
Mar 6, 2017
35066_dirs_2017-03-06_be7bcf77-04cb-491e-abf2-b7c1f2effdbf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2017-02-23
Reporting Person: Martin James Joseph (N/A)
More from Cocrystal Pharma, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15